NSE · SMSPHARMA
SMS Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#883
of 5,004 stocks
🏆 New peak
▲ 271W
Peak #883 · 01 Oct 2026
SMS Pharmaceuticals Limited is a smallcap company in the Healthcare space and remains firmly promoter-controlled, with promoters holding 68%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
4,463.45 Cr
P/E Ratio
42.74
P/B Ratio
5.68
ROE
12.98%
ROCE
13.84%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 206.96 Cr | 237.95 Cr | 210.45 Cr | 242.43 Cr |
| Net Profit | 20.91 Cr | 32.71 Cr | 23.47 Cr | 25.31 Cr |
| EPS | 2.23 | 3.58 | 2.59 | 2.84 |
| Operating Profit | 32.70 Cr | 32.34 Cr | 37.38 Cr | 39.78 Cr |
Shareholding pattern
Promoter
68.07%
Public
31.93%
Mutual fund holdings
₹56.98
Cr total
3
Schemes
2
Fund Houses
₹56.98 Cr
Total Exposure
Quant Mutual Fund₹56.95 Cr (99.9%)
Motilal Oswal Mutual Fund₹0.03 Cr (0.1%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 22 Sep 2026 | Dividend | Dividend - Re 0.40 Per Share |
| 22 Sep 2025 | Dividend | Dividend - Re 0.40 Per Share |
| 23 Sep 2024 | Dividend | Dividend - Rs 0.40 Per Share |
| 23 Sep 2024 | Other | Annual General Meeting |
| 22 Sep 2023 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.